2019
DOI: 10.1101/667311
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Prenatal Diagnosis of Fetuses with Increased Nuchal Translucency by Genome Sequencing Analysis

Abstract: 1 Background: 2 Increased Nuchal Translucency (NT) is an important biomarker associated with increased 3 risk of fetal structural anomalies. It is known to be contributed by a wide range of genetic 4 etiologies from single nucleotide variants to those affecting millions of base-pairs. 5 Currently, prenatal diagnosis is routinely performed by karyotyping and chromosomal 6 microarray analysis (CMA), however, both of them have limited resolution. The diversity 7 of the genetic etiologies warrants an integrated as… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 42 publications
(58 reference statements)
1
5
0
Order By: Relevance
“…Ultrasound scans showed a range of abnormalities including increased nuchal translucency, pleural effusion, cardiac anomaly, renal anomalies, intrauterine growth restriction, polyhydramnios, oligohydramnios and single umbilical artery. Similar antenatal presentations were also noted in the recent large case series and published case reports 8–40 . More than half of the cases were diagnosed after birth by clinical assessment and molecular testing.…”
Section: Discussionsupporting
confidence: 78%
“…Ultrasound scans showed a range of abnormalities including increased nuchal translucency, pleural effusion, cardiac anomaly, renal anomalies, intrauterine growth restriction, polyhydramnios, oligohydramnios and single umbilical artery. Similar antenatal presentations were also noted in the recent large case series and published case reports 8–40 . More than half of the cases were diagnosed after birth by clinical assessment and molecular testing.…”
Section: Discussionsupporting
confidence: 78%
“…Therefore, prenatal diagnosis by CMA instead of expanded NIPS is highly recommended for high-risk pregnancies. Recently, the development of genome sequencing, including CNV sequencing and low-pass whole-genome sequencing, has shown the potential of next-generation sequencing for the detection of genome-wide variants 36,37 , including balanced rearrangements 38 and single nucleotide variants 39 , that cannot be detected by CMA. The implementation of invasive diagnostic testing by genome sequencing in high-risk pregnancies may provide even more comprehensive genetic information.…”
Section: Discussionmentioning
confidence: 99%
“…For fetuses with structural anomalies, prenatal whole exome sequencing (WES) has been successfully applied for clinical testing to facilitate genetic diagnosis, thereby enabling more accurate predictions of fetal prognosis and information on the risk of recurrence in future pregnancies 23‐25 . A recent study had also showed the feasibility of applying genome sequencing (GS) for prenatal diagnosis of fetuses with increased NT for comprehensive detection of various disease‐causing genomic variants 26 . However, accurate prenatal diagnosis of skeletal dysplasia by invasive procedures is still under debate in the absence of a relevant family history, and the time from invasive testing to diagnosis can be lengthy 12 .…”
Section: Discussionmentioning
confidence: 99%